IMMUNITYBIO, INC. Restricted Cash and Cash Equivalents, Noncurrent
IMMUNITYBIO, INC. (IBRX) had Restricted Cash and Cash Equivalents, Noncurrent of $1.28 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-04
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $1.28M.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $1.28M.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $1.10M.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $1.10M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-06-30 | $1.28M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.10M 10-K · filed 2026-02-23 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $484.00K 10-Q · filed 2026-08-04 |
| 2025-03-31 | $484.00K 10-Q · filed 2026-05-07 |
| 2024-12-31 | $484.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $334.00K 10-Q · filed 2025-11-05 |
| 2024-06-30 | $334.00K 10-Q · filed 2025-08-05 |
| 2024-03-31 | $334.00K 10-Q · filed 2025-05-12 |
| 2023-12-31 | $334.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $334.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $324.00K 10-Q · filed 2024-08-12 |
| 2023-03-31 | $324.00K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $324.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $324.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $324.00K 10-Q · filed 2023-08-08 |
| 2022-03-31 | $179.00K 10-Q · filed 2023-05-11 |
| 2021-12-31 | $179.00K 10-K · filed 2024-03-19 |
| 2021-09-30 | $179.00K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $179.00K 10-Q · filed 2022-08-08 |
| 2021-03-31 | $179.00K 10-Q · filed 2022-05-10 |
| 2020-12-31 | $179.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $179.00K 10-Q · filed 2021-11-12 |
| 2020-06-30 | $179.00K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $179.00K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $179.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $179.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $179.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $179.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $179.00K 10-K · filed 2021-03-04 |
| 2018-09-30 | $179.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $179.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $179.00K 10-Q · filed 2018-05-07 |
| 2017-12-31 | $179.00K 10-K · filed 2020-03-25 |
| 2017-09-30 | $179.00K 10-Q · filed 2018-11-07 |
| 2017-06-30 | $179.00K 10-Q · filed 2018-08-06 |
| 2017-03-31 | $179.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $179.00K 10-K · filed 2019-03-13 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |